News
-
Impel NeuroPharma has named Leonard S. Paolillo as Chief Commercial Officer and Gerald F. Penn as VP, Market Access and Trade in anticipation of the launch of Trudhesa intranasal dihydroergotamine mesylate (DHE) for the treatment… Read more . . .
-
OINDP testing specialist Copley Scientific has announced upgrades to the company’s inhaler testing equipment range, including new products such as the Inhaler Testing Workstation (ITW) and updates to its TPK critical flow controllers, BAC 2100 breath… Read more . . .
-
Atossa Therapeutics announced that a two-week Phase 1 study evaluating the safety of two dose levels of the company’s AT-301 nasal spray in healthy volunteers demonstrated that the nasal spray was safe and well tolerated.… Read more . . .
-
Reflections by Philip Kuehl and Jacob McDonald, Lovelace Biomedical What a year! 2020 was the year when those of us in aerosol science were forced to stop compartmentalizing. It was the year that we could… Read more . . .
-
Virpax Pharmaceuticals said that the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health has begun pre-clinical studies of Virpax’s Envelta intranasal enkephalin to support an IND submission. Virpax signed a cooperative… Read more . . .
-
Starpharma said that it is set to launch its Viraleze astodrimer sodium antiviral nasal spray within the next month after receiving approval to market the nasal spray in Europe and the UK. In September 2020,… Read more . . .
-
Aridis Pharmaceuticals announced that it is now receiving preclinical support from the NIAID (National Institute of Allergy and Infectious Diseases) and CoVIC (Coronavirus Immunotherapy Consortium) for a nebulized monoclonal antibody cocktail for COVID-19 and that… Read more . . .
-
According to Union therapeutics, the Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge have begun recruiting kidney patients for a clinical trial of Union’s UNI91103 intranasal niclosamide for the prevention of COVID-19 in vulnerable patients.… Read more . . .
-
Glenmark Pharmaceuticals announced that the Ministry of Health of the Russian Federation has approved Ryaltris olopatadine / mometasone furoate nasal spray for the treatment of seasonal and perennial allergic rhinitis, and the company expects to launch the… Read more . . .
-
According to Microbion Corporation, the company has received up to $1.8 million from the Cystic Fibrosis Foundation to fund toxicology studies to support an IND for the company’s pravibismane inhalation suspension for the treatment of… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.